K.Vita Dietary Management | Vitaflo UK & ROI

Nutritional Information

K.Vita Research

HCP Resources

Practical Guides: Adults

Practical Guides: Children

Interested in K.Vita?

K.Vita, an alternative dietary management for drug resistant epilepsy.

K.Vita is an exciting new option to manage patients, from 3 years of age, who have drug resistant epilepsy, with minimal dietary restriction.

K.Vita is a unique blend of medium chain fatty acids (decanoic acid - C10 and octanoic acid - C8) with a palatable strawberry flavour. It is important that K.Vita is introduced slowly, over four weeks, to help establish gastrointestinal tolerance to medium chain triglycerides (MCT). K.Vita is taken as part of the patient’s usual diet. However, as advised during the clinical trial, to optimise nutritional intakes, it is recommended that foods and beverages high in sugar are avoided.

Each 120ml pack contains:

40g bespoke blend of MCT
Higher levels of decanoic acid (C10) than regular MCT
80:20 ratio of C10:C8

Nutritional Profile and Datacard

Nutritional Information		Per 100ml	Per 120ml pack
Energy	kJ	1265	1526
Energy	kcal	308	371
Fat	g	34	41
of which saturates	g	31	37
Medium Chain Triglycerides (MCT)	g	33.5	40
Caprylic / Octanoic Acid (C8:0)	g	6.2	7.4
Capric / Decanoic Acid (C10:0)	g	24.5	29.4
Carbohydrate	g	0.42	0.50
of which sugars	g	0	0
Protein	g	0	0
Salt	g	0.11	0.13
Sodium	mg	46	55
Sodium	mmol	2.0	2.4
Chloride	mg	56	67
Chloride	mmol	1.6	1.9

Download the K.Vita datacard

Allergen, Kosher and Halal Information

View the Allergen, Kosher and Halal Matrices

K.Vita Research

Service evaluation: Will you help us gather more real-world evidence to support its use?

The K.Vita service evaluation is co-ordinated by Dr Natasha Schoeler, Research Dietitian n.schoeler@ucl.ac.uk at University College London Great Ormond Street Institute of Child Health, London, UK in collaboration with Vitaflo (International) Ltd. Download the Service Evaluation Overview to find out how to get involved.

Clinical Research Paper

Please download the clinical research paper to learn more about how K.Vita was implemented and accepted in the feasibility study: K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy.

Go to clinical research paper

Global Symposium

Vitaflo sponsored symposium at the 7th Global Symposium on Medical Ketogenic Diet Therapies discussing the latest research for an alternative dietary management for drug resistant epilepsy.

Watch on VIA

HCP Resources

Vitaflo in Association (VIA) is an education portal that houses innovative educational resources for healthcare professionals. It offers a range of content for the following disorder areas: Inborn errors of metabolism, Ketogenic diet, Paediatric kidney disease, Lipid disorders, Glycogen storage disease and Nutrition support. Resources include case studies, webinar and even recordings and practical resources.

K.Vita Introduction Plan Calculator

The calculator is for the creation of an individualised K.Vita introduction plan as an alternative to the pre-prepared four-week plans in the two patient K.Vita guides: ‘A guide for children taking K.Vita’ and ‘A guide for adults taking K.Vita.'

Download from VIA

Practical Guides

For Adults

Use of K.Vita in the dietary management of adults with drug resistant epilepsy

This guide provides the HCP with information on how to introduce and take K.Vita during the first four weeks.

View on VIA

Introduction to adults taking K Vita form

A Guide for Adults Taking K.Vita

This guide provides patients and carers with instructions for taking K.Vita during the first four weeks and includes an easy to follow 4-week introduction schedule.

View on VIA

For Children

Use of K.Vita in the dietary management of children with drug resistant epilepsy

This guide provides the HCP with information on how to introduce and take K.Vita during the first four weeks.

View on VIA

Introduction to children taking K Vita form

A Guide for Children Taking K.Vita

This guide provides patients and carers with instructions for taking K.Vita during the first four weeks and includes an easy to follow 4-week introduction schedule.

View on VIA

Interested in K.Vita?